Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COLISTIMETHATE vs COPANLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

COLISTIMETHATE vs COPANLISIB: Safety Overview

Metric COLISTIMETHATE COPANLISIB
Total FAERS Reports 845 355
Deaths Reported 142 45
Death Rate 16.8% 12.7%
Hospitalizations 348 213
Average Patient Age 46.4 yrs 64.1 yrs
% Female Patients 46.9% 39.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 14, 2017
Manufacturer Xellia Pharmaceuticals USA LLC N/A
Route INTRAMUSCULAR N/A
Marketing Status Prescription Discontinued